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http:WHAT THIS PAPER ADDS
There have only been a few studies published on the treatment of inadvertent intra-arterial injection of dis-
solved tablets containing sedatives, such as ﬂunitrazepam, with - in part - unsatisfactory clinical results. Here, we
report on the good outcome of 13 out of 16 drug abusers who had injected themselves intra-arterially with
ﬂunitrazepam leading to critical limb ischaemia. Treatment according to a standardized protocol prevented
irreversible tissue damage in 14 out of 16 patients, even when delayed treatment. As the general outcome was
improved and adverse effects or therapy-associated complications were not observed, this protocol is suitable
for clinical practice.Objectives: Inadvertent intra-arterial injection of ﬂunitrazepam tablets intended for intravenous use by drug
abusers has devastating effects. We report here on the clinical outcome of 16 drug abusers developing critical
limb ischaemia after ﬂunitrazepam injection.
Methods: Treatment combined immediate analgesia and anticoagulation, long-lasting local thrombolysis and
vasodilatation, antibiotic prophylaxis, and physical mobilization. The immediate bolus injection of 5,000 IU
heparin was followed by a continuous heparin infusion up to the target partial thromboplastin time. Under
arteriographic control local intra-arterial infusion with alternating 4-h cycles of 5 mg recombinant tissue
plasminogen activator followed by 5 mg prostaglandinE1 (PGE1) was performed for 24e48 hours. Subsequently,
60 mg PGE1 was applied once daily.
Results: Drug abusers, having been injected with 4e30 mg ﬂunitrazepam, were treated 3e72 hours after the
accident, with six of them not being treated until after 24 hours. All showed a high tissue ischaemia score. At the
time of being discharged from hospital 13 patients had a normal extremity. In one patient, ﬁrst receiving
treatment 72 hours after injection, minor amputation of ﬁngers was necessary. The life of the patient who
injected 30 mg ﬂunitrazepam in the leg was saved after hip disarticulation. One patient developed neurological
dysfunction in the affected toes.
Conclusions: Intensive treatment after inadvertent intra-arterial drug injection normalized the affected extremity
in most drug abusers, even after the late onset of therapy.
 2013 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.
Article history: Received 17 May 2013, Accepted 18 September 2013, Available online 4 October 2013
Keywords: Drug abuse, Flunitrazepam, Intra-arterial injection, Local thrombolysis, Prostaglandin E1INTRODUCTION
The misuse of drugs for recreational purposes has increased
the number of inadvertent intra-arterial injections of
crushed, dissolved tablets containing sedatives or narcotics,
which often results in critical limb ischaemia, culminating in
the risk of limb amputation. Flunitrazepam, a benzodiaze-
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//dx.doi.org/10.1016/j.ejvs.2013.09.028abused to reduce the stimulant effects of cocaine, and in
combination with heroin to enhance the effects of the drug
and to ameliorate withdrawal.1e3 Flunitrazepam is pre-
scribed in Europe and Latin America for the treatment of
insomnia and as a pre-anaesthetic medication, but has not
been approved in the USA. In Germany it was scheduled
under the narcotic drugs act to decrease misuse in 2011.
Intra-arterial injection of crushed, dissolved tablets con-
taining multiple constituents, such as microcrystalline cel-
lulose or magnesium stearate, by drug abusers leads to
adverse effects on blood ﬂow and the vascular endothe-
lium. Additionally, the tablets are invariably contaminated
with impurities when procured illegally. In contrast to iat-
rogenic intra-arterial drug injection, after inadvertent intra-
arterial injection in drug abusers much more time is lost
62 S. Rohm et al.until effective therapy, thus increasing the risk of critical
limb ischaemia. Early diagnosis of the ischaemic syndrome
followed by an immediate effective therapy is essential for
complete limb rescue.
Only case studies on the treatment of inadvertent intra-
arterial injection of ﬂunitrazepam tablets have been pub-
lished so far.4e9 A literature search revealed that a generally
accepted treatment algorithm for accidental intra-arterial
drug injection to stop critical limb ischaemia is missing. A
variety of substances and therapies, and their combinations,
has been used. Anticoagulation and vasodilation,5,10e13
and/or local ﬁbrinolysis6e9,14,15 are integral parts of many
treatment protocols. Haemodilution with low molecular
weight dextran,11,16 continuous plexus blocks and regional
nerve blocks for sympathicolysis,13,17 and corticosteroids5,16
are also often applied, whereas sympathetic antagonists18
and hyperbaric oxygen therapy combined with antiplatelet
agents4 have rarely been used. The small number of pa-
tients involved in most of these empiric studies made it
difﬁcult to develop an effective well-accepted treatment
protocol.
The objective of this study is to report the outcomes of
patients after inadvertent intra-arterial injection of ﬂuni-
trazepam tablets, and suffering subsequent critical limb
ischaemia, after treatment according to a novel standard-
ized protocol.PATIENTS AND METHODS
Patients
The retrospective study included drug abusers with critical
limb ischaemia following accidental intra-arterial injection
of dissolved ﬂunitrazepam tablets who were admitted to
the emergency ward of the Vascular Surgery Unit, Univer-
sity of Leipzig, within a 36-month period before 2011. After
this period admissions of such patients to this hospital
stopped, probably because ﬂunitrazepam was scheduled
under the narcotic drugs act in 2011.
As we combined common clinical routine steps, the
treatment regimen did not need ethical approval.Diagnosis
After admission to the hospital, the patients’ histories were
taken. Motor and sensory deﬁcits of the injected extremity
were measured using sharpedull or two-point discrimina-
tion. Missing sensory function was judged as abnormal. The
colour and temperature of the injected extremity were
assessed. Cyanotic and cool/cold limb were judged as
abnormal. Pulses of the common femoral, popliteal, and
anterior/posterior tibial arteries, aswell as of the brachial and
radial/ulnar arteries, were assesseddif the drugwas injected
into the leg or armdby high-resolution colour-coded duplex
sonography. Capillary reﬁll was assessed at the most distal
extent of injury. A time delay of more than 3 seconds was
judged as abnormal. In summary, a tissue ischaemia score,
including the four assessed clinical signs of sensory function,
colour, temperature, and capillary reﬁll of the affectedextremity,was used to judge ischaemic injury.16 Each signwas
scored either normal (¼ 0) or abnormal (¼ 1), and then they
were summed up to provide the tissue ischaemia score in the
range of 0 to 4. The score was established by Treiman et al.16
Until now this score could not be validated because of the low
number of patients that was included in studies that were
published subsequently.
After taking the patient’s medical history and ﬁrst diag-
nosis, a high-dose analgesia with 7.5e15.0 mg piritramide
(Dipidolor; Janssen-Cilag, Neuss, Germany) was promptly
injected intravenously (i.v.). Next, each patient received
detailed information on the clinical consequences of intra-
arterial tablet injection and on further treatment.
Dependent on the affected extremity, transfemoral or
transbrachial arteriography with a 5-F introducer set was
performed in each patient, at ﬁrst for further diagnostic
analysis, and, second, to initiate local thrombolysis with
recombinant tissue plasminogen activator (rt-PA) in the
affected extremity. Arteriography was carried out using a
Siemens Artis zeego multi-axis System (Siemens Deutsch-
land, Munich, Germany).
Treatment regimen
Owing to the fact that therapeutic guidelines are still
missing, we established an intensive treatment protocol
based on published data on inadvertent intra-arterial in-
jection of dissolved ﬂunitrazepam and other tablets or gels.
The protocol is summarized schematically in Fig. 1.
Well-accepted single therapeutic interventional and
conservative steps consisting of analgesia, anticoagulation,
vasodilation, local thrombolysis, antibiotic prophylaxis, and
physical mobilization were combined. Directly after detailed
information had been provided to the patient and diag-
nostic arteriography, the following treatment algorithm was
applied:
1. Anticoagulation was started by an i.v. bolus application
of 5,000 IU heparin (Liquemin; Roche-Pharma,
Grenzach-Wyhlen, Germany), followed by continuous
heparin infusion i.v. until partial thromboplastin time
was 2.0e2.5 times higher compared with control value.
2. To ﬁbrinolyse local thrombi in the affected limb and to
prevent systemic thrombosis, a 4-h local intra-arterial
infusion of 5 mg rt-PA (Actilyse; Boehringer-Ingelheim
Pharma, Ingelheim, Germany) was alternated with a
4-h intra-arterial application of 5 mg prostaglandin
E1 (PGE1) (Prostavasin; Schwarz Pharma, Monheim,
Germany). These 4-h cycles were continued over
24e48 hours. Arteriographic control was performed
for the ﬁrst time 24 hours after beginning ﬁbrinolytic
therapy and was repeated every 12 hours until the
occluded vessels were free. If there was no
improvement seen by arteriography at the 48-hour
time point, intra-arterial ﬁbrinolytic therapy was
stopped.
3. To maintain the vasodilatatory effect the therapy was
continued with 60 mg PGE1 once daily i.v. up to
discharge from the hospital.
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analgesia
informing and advising the patient
5000IU heparin bolus
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Figure 1. Diagram of the treatment protocol.
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administered 3  1.5 g i.v. daily (Cefuroxim;
Ratiopharm, Ulm, Germany) to prevent infection in the
ischaemic tissue after the unsterile technique of self-
injection.19
5. Sufﬁcient elevation of the affected extremity and early
physical therapy, to reduce oedema and minimize
stasis and the development of contractures or residual
motor deﬁcits of the affected extremity, are further
therapeutic measures. Passive mobilization was applied
immediately after the bolus injection of heparin (three
times daily, 20e30 minutes each). Active physiotherapy
was started after ﬁnishing the intra-arterial ﬁbrinolytic
therapy and was also applied 2e3 times daily.
Statistics
For all parameters median and interquartile range [25the
75th percentile] were used.
RESULTS
Clinical examination of the patients
Table 1 summarizes the clinical and anthropometric char-
acteristics, treatment, and outcome of patients. The 16
patients (aged 24.0 [20.0e36.0] years old), sought medicaladvice after 20 [5e32] hours. In 6/16 patients this was
more than 24 hours after accidental injection.
The clinical picture of intra-arterial injection of crushed
tablets is very typical. After taking the patient’s medical
history, a wrong diagnosis is impossible. All patients noted a
sudden excruciating burning pain with increasing intensity
immediately after intra-arterial injection of ﬂunitrazepam in
the affected extremity. At admission, these extremities were
swollen and appeared cyanotic in all patients, and the limb
skin was mottled blue or blue-green distal to the injection
site. The tissue ischaemia score ranked between 3 and 4. In
13 out of 16 cases the occlusion was purely microvascular.
Here, the distal pulse in the affected limb was normal or
accentuated by the outﬂow block. Pulses were absent in
three cases. There were no pulses femoral and below in
patient 4, who had injected 30 mg ﬂunitrazepam. The other
two patients, who arrived at the hospital 48 and 72 hours
after injection, had partial pulse defects in the affected
limb. All patients developed an oedema, which may in-
crease compartment pressure and has a deleterious effect
on the tenuous microcirculatory haemodynamics. All pa-
tients had motor and sensory deﬁcits in the affected limb.
The patients injected dissolved ﬂunitrazepam tablets
containing 6.0 [4.5e8.0] mg of the active agent. In one
case, 30 mg ﬂunitrazepam was applied. The tablets were
crushed and dissolved in tap water.
Treatment
Piritramide analgesia was the immediate standard analgesic
therapy; other forms of opiates were not tested. This drug
shows a very good and fast analgesic effect, and could be
injected subcutaneously or i.v. during therapy. After anal-
gesia and providing detailed information on the risks of
critical limb ischaemia and further treatment, acceptable
compliance was achieved in all patients under therapy.
The alternating intra-arterial cycling therapy with rt-PA
and PGE1 infusions was applied for 36.0 [24.0e36.0]
hours until patients had a resolution of symptoms yielding a
normal extremity, or until a stable morphological or
neurological deﬁcit. The tip of the catheter for ﬁbrinolytic
therapy and heparin infusion was always localized in the
area of occlusion. In patients with accidental injection into
the brachial/radial artery, the catheter was introduced
retrograde into the femoral artery. In patients with an
affected lower extremity the catheter was introduced
antegrade into the femoral artery of the same site. A cross-
over technique was only applied in patient 4, that is the
catheter was introduced into the femoral artery of the
other, unaffected leg. Arteriograms of two typical patients
after the injection of dissolved ﬂunitrazepam before and 24
hours after treatment onset are shown in Fig. 2.
Even after a delay of 48 hours between accident and
treatment onset, patency of the occluded arteries was
achieved.
Noneof the patients, except patient 4,weremonitored in an
intensive care unit. However, during locoregional ﬁbrinolytic
therapy, electrocardiogram, pulse, blood pressure, and oxy-
metry were recorded continuously.
Table 1. Clinical and anthropometric characteristics, treatment, and outcome of patients after inadvertent intra-arterial injection of dissolved ﬂunitrazepam.
Patient Sex Age
(y)
Injected
artery
Injected
ﬂunitrazepam
(mg)
Time to
treatment
(h)
Tissue
ischaemic
score
Pulsea Compartment
syndrome
Duration of
local thrombolysis,
intra-arterial PGE1 (h)
Hospitalization
(d)
Surgical
intervention
Outcome
1 F 23 Brachial 6 15 3 Uþ/Rþ e 24 6 e Normal
2 F 23 Radial 4 22 4 Uþ/Rþ e 24 7 e Normal
3 M 36 Femoral 10 24 4 Aþ/Pþ e 48 14 e Normal
4 M 35 Femoral 30 18 4 A-/P- þ 24 31 b Limb
amputation
5 F 24 Brachial 6 3 3 Uþ/Rþ e 24 6 e Normal
6 M 30 Brachial 6 32 4 Uþ/Rþ e 36 9 e Normal
7 F 22 Femoral 8 5 3 Aþ/Pþ e 36 7 e Normal
8 M 23 Brachial 10 4 4 Uþ/Rþ e 36 9 e Normal
9 F 20 Brachial 6 5 3 Uþ/Rþ e 24 6 e Normal
10 M 24 Radial 8 72 4 Uþ/R- e 48 28 c Minor
amputation
11 F 28 Brachial 4 3 3 Uþ/Rþ e 24 3 e Normal
12 F 25 Femoral 6 48 4 A-/Pþ e 36 7 e Motor deﬁcit
13 M 23 Brachial 4 31 4 Uþ/Rþ e 36 11 e Normal
14 M 23 Femoral 8 26 4 Aþ/Pþ e 48 9 e Normal
15 M 24 Femoral 6 37 4 Aþ/Pþ e 24 6 e Normal
16 M 28 Radial 4 7 4 Uþ/Rþ e 36 8 e Normal
Note. PGE1 ¼ prostaglandin E1; U ¼ ulnar; R ¼ radial; A ¼ anterior tibial; P ¼ posterior tibial; þ ¼ pulse present; e ¼ pulse absent.
a Arm: U/R artery; leg: A/P artery.
b Thrombectomy, fasciotomy, hip exarticulation.
c Distal interphalangeal amputation ﬁngers IIeV.
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Figure 2. Arteriograms of two women after inadvertent intra-
arterial injection of dissolved ﬂunitrazepam tablets before and
24 h after treatment onset with intra-arterial local tissue ﬁbrino-
lysis and vasodilation using alternating 4-h tissue plasminogen
activator and prostaglandin E1 infusions for 24 h. (A, B) Digital
artery occlusion after 6 mg intra-brachial ﬂunitrazepam injection
(patient 9, Table 1) before therapy (A) and after 24 h of ﬁbrolysis
and vasodilation (B) demonstrating patency of the digital arteries
after treatment. (C, D) Distal occlusion of the posterior and
anterior tibial arteries following intra-femoral injection of 6 mg
ﬂunitrazepam (patient 12, Table 1) before therapy (C) and 24 h
after treatment onset (D) demonstrating almost complete patency
of the arteries. Time delay between accidental injection and
treatment was 48 h.
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After treatment, 13/16 patients had a normal extremity
without morphological and functional alterations. One pa-
tient retained a neurological dysfunction: the affected toeswere contracted permanently. In two patients surgical in-
terventions were necessary. In the patient who had a time to
treatment after injection of 72 hours, distal interphalangeal
borderline amputation of ﬁngers II, III, IV, and V was
necessary because of tissue necrosis. Amputation was per-
formed after clear tissue demarcation had developed. The
patient who injected 30 mg ﬂunitrazepam, that is 15 crushed
dissolved tablets, developed an ischaemic compartment
syndrome of the affected leg, caused by excessive rhabdo-
myolysis, and multi-organ failure evolved. In order to save
the patient’s life hip exarticulation was necessary.
Although all patients injected the dissolved ﬂunitrazepam
tablets in non-sterile conditions, spreading infections and
wet gangrene were not observed under antibiotic prophy-
laxis with cephalosporin. The median duration of hospitali-
zation was 7.5 [6.0e10.5] days.
Complications such as bleeding, pseudoaneurysms, or
arteriovenous ﬁstulae were not seen. Only haematomas,
not liable to therapy, were induced.DISCUSSION
Here we report on the good clinical outcome of 16 drug
abusers who developed critical limb ischaemia after inad-
vertent intra-arterial injection of crushed, dissolved ﬂuni-
trazepam tablets, and were treated with an intensive
protocol combining immediate analgesia and anti-
coagulation, long-lasting local thrombolysis and vasodilata-
tion, antibiotic prophylaxis, and physical mobilization. Even
in 4/6 patients who received this therapy later than 24
hours after the accidental drug injection, the extremity
returned to normal without any morphological damage or
functional adverse effect after treatment.
Compared with other studies, our report includes an
unusually high number of patients with inadvertent intra-
arterial injection of ﬂunitrazepam. This is caused, in part,
by the fact that ﬂunitrazepam was legally available for sale
in Europe and Latin America, but was never marketed in the
USA, for example, probably because it has no therapeutic
advantage over the benzodiazepines presently marketed
there, or because of its greater liability for abuse as a date-
rape drug compared with other benzodiazepines.1,2 Sixteen
patients within a 3-year period is, nevertheless, high for a
German city, suggesting its easy, illegal, availability within
the catchment area of the university emergency ward
during this period.
Overall, we established an intensive treatment protocol
that enabled a good clinical outcome in most patients. Only
one patient, who, incredibly, had injected 15 dissolved ﬂu-
nitrazepam tablets, developed catastrophic complications.
After complete ischaemia in the affected leg resulting in
severe rhabdomyolysis and multi-organ failure, amputation
of the extremity was the only live-saving option.
In our treatment protocol we ﬁrst minimized the risk of
coagulation by an immediate bolus injection of heparin. The
subsequent continuous heparin infusion maintains patent
collaterals and capillary microcirculation, inhibits further
propagation of thrombi, and prevents thrombosis in small
66 S. Rohm et al.veins, thereby preventing outﬂow obstruction, stasis, and
occlusion of the distal arteries.11 High-resolution colour-
coded duplex sonography is useful to deﬁne the extent of
injury at treatment onset.5,15
Patients’ compliance was improved by (i) immediate
adequate analgesia because the excruciating severe
ischaemic pain decreases further the poor compliance of
drug abusers,7 and (ii) detailed information provided to the
patient on the imminent risk of extremity amputation.
Consequently, the complete treatment protocol could be
carried out in all patients.
Moreover, local thrombolysis and vasodilation by alter-
nating intra-arterial infusion of rt-PA and PGE1 was
continued until success or unchanged arteriographic result.
The combination of both substances stops the pathophysi-
ological cascade and ischaemic process.6,7,14,18,20 PGE1
markedly enhances the ﬁbrinolytic efﬁcacy of rt-PA and
does so, in part, by inhibiting platelet aggregation.20 It has
its own multiple beneﬁcial effects on circulation.20,21
Consequently, our combined intra-arterial therapy with
heparin and alternating rt-PA and PGE1 shows better ther-
apeutic resultsdrecovery of the affected limbs in 80% of
our patientsdafter peripheral arterial occlusions compared
with other treatment protocols, although all patients were
admitted with a worse tissue ischaemia score and 6/16
more than 24 hours after accidental injection.7,12,16,22
Treiman et al.16 treated 48 drug abusers, who had
injected 13 different substances in various brachial arteries,
by application of heparin, dextran 40, and dexamethasone.
A good outcome was achieved only when therapy was
started within the ﬁrst 24 hours after injection. A longer
delay in treatment onset resulted in a high rate of border-
line amputation, which conﬁrmed other studies showing
that early onset of therapy is a major determinant of good
clinical outcome.4,6,12,13 Moreover, in the study by Treiman
et al.16 only 50% of the patients had a tissue ischaemia
score of 3 or higher, as had all patients in our study. Three
patients retained functional deﬁcits and in 11 patients
digital amputations were necessary, that is 30% had an
unsatisfying clinical outcome, whereas in our study defects
remained in only 19% of the patients.
The mechanism of ischaemic injury following intra-arterial
drug injection is not completely understood. Direct toxicity of
the injected drug to the endothelium,23 increased sympa-
thetic vasospasm,24 increased platelet aggregation and acid
crystal formation,25 thromboxane release,18,26 and particu-
late emboli27,28 have been previously discussed as triggering
factors for the initial insult. Only a few experimental in vivo
studies using the rabbit ear model, which reﬂects insufﬁcient
human vascular anatomy, were performed in the 1980s to
examine the intra-arterial effects of tablet constitu-
ents.18,19,26,29 Intra-arterial injection of microcrystalline cel-
lulose, a puriﬁed depolymerized form of cellulose that is used
as a binder in tablets caused direct toxicity to the endothe-
lium.19,29 Arterial and venous endothelial injury results in the
development of venospasm, venous thrombosis, and,
secondarily, transient arterial vasoconstriction in the capillary
bed up to the occlusion of arterioles and distalarteries.13,14,25,30 The capillary pressure increases due to the
slowed capillary blood ﬂow with the consequence of ﬂuid
transudation into the interstitium causing impaired soft tis-
sue perfusion and ischaemia in the areas concerned.31 Clin-
ically, these events present as severe oedema followed
rapidly by stagnation of blood ﬂow with cyanosis. The
development of arterial insufﬁciency and tissue hypoxia re-
sults in temperature loss, progressive neurologic deteriora-
tion, and, ultimately, gangrene.16 Irreversible tissue loss of
affected extremities occurs in most untreated patients.32
The number of articles describing cases of accidental
injection of crushed tablets has decreased. In part, this is
owing to re-classiﬁcation of these drugs as narcotics and to
other dosage forms. Flunitrazepam-producing companies
changed the tablet composition such as for rohypnol
(Roche). They added colouring and agglutinating sub-
stances, and a bitter ﬂavour to prevent further misuse as a
date-rape drug and as an i.v. narcotic in drug abusers.
However, generic drug-producing companies did not
implement these obvious requirements.
In summary, our treatment protocol for patients with
inadvertent intra-arterial injection of dissolved ﬂuni-
trazepam tablets was very effective. Interactions between
ﬂunitrazepam and the agents given during treatment are
unknown or have not been described. Together with stan-
dard heparin therapy, the alternating combined intra-
arterial treatment with thrombolytic rt-PA and vaso-
dilatatory PGE1 prevented irreversible tissue damage in
most patients without an increased bleeding risk. The
application of immediate adequate pain treatment and
early mobilization of the affected extremity further
increased therapy success. The general outcome, also in
late-onset of therapy, was improved and adverse effects or
therapy-associated complications were not observed.
The protocol was used only in the clinical situation
described because patients who had injected other drugs
were not admitted to our clinic. Theoretically, the treatment
algorithm is transferrable to every accident involving intra-
arterially injected crushed tablets or gels. After accidental
clinical intra-arterial injection a less rigid protocol will
probably be successful because time delay until treatment
will not be as long as it was in our study with drug abusers.
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